Product Information

Total Page：16

File Type：pdf, Size：1020Kb

Product information PLDN, 1-172aa Human, His-tagged, Recombinant, E.coli Cat. No. IBATGP1472 Full name: pallidin NCBI Accession No.: NP_036520 Synonyms: HPS9, PA, PALLID Description: PLDN (Pallidin) may play a role in intracellular vesicle trafficking. It interacts with Syntaxin 13 which mediates intracellular membrane fusion. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. This protein involved in the development of lysosome-related organelles, such as melanosomes and platelet-dense granules. PLDN has been shown to interact with BLOC1S1, STX12, Dysbindin, CNO, BLOC1S2, MUTED and SNAPAP. Recombinant human PLDN protein, fused to His-tag at N-terminus, was expressed in E.coli and purified by using conventional chromatography techniques. Form: Liquid. In 20mM Tris-HCl buffer (pH 8.0) containing 2mM DTT, 10% glycerol, 100mM NaCl Molecular Weight: 21.9kDa (192aa), confirmed by MALDI-TOF (Molecular weight on SDS-PAGE will appear higher) Purity: > 90% by SDS - PAGE Concentration: 1mg/ml (determined by Bradford assay) 15% SDS-PAGE (3ug) Sequences of amino acids: MGSSHHHHHH SSGLVPRGSH MSVPGPSSPD GALTRPPYCL EAGEPTPGLS DTSPDEGLIE DLTIEDKAVE QLAEGLLSHY LPDLQRSKQA LQELTQNQVV LLDTLEQEIS KFKECHSMLD INALFAEAKH YHAKLVNIRK EMLMLHEKTS KLKKRALKLQ QKRQKEELER EQQREKEFER EKQLTARPAK RM General references: Huang L, et al. (1999). Nat Genet 23 (3): 329–32. Moriyama K., et al. (2002) Traffic 3:666-677 Storage: Can be stored at +4°C short term (1-2 weeks). For long term storage, aliquot and store at -20°C or -70°C. Avoid repeated freezing and thawing cycles. For research use only. This product is not intended or approved for human, diagnostics or veterinary use. Immuno-Biological Laboratories, Inc. (IBL-America) 8201 Central Ave. NE, Suite P, Minneapolis, Minnesota 55432, USA Phone: (888) 523-1246 Fax.: (763) 780-2988 Email: [email protected] Web: www.ibl-america.com.

Copy Link

Recommended publications

Mouse Germ Line Mutations Due to Retrotransposon Insertions Liane Gagnier1, Victoria P
Gagnier et al. Mobile DNA (2019) 10:15 https://doi.org/10.1186/s13100-019-0157-4 REVIEW Open Access Mouse germ line mutations due to retrotransposon insertions Liane Gagnier1, Victoria P. Belancio2 and Dixie L. Mager1* Abstract Transposable element (TE) insertions are responsible for a significant fraction of spontaneous germ line mutations reported in inbred mouse strains. This major contribution of TEs to the mutational landscape in mouse contrasts with the situation in human, where their relative contribution as germ line insertional mutagens is much lower. In this focussed review, we provide comprehensive lists of TE-induced mouse mutations, discuss the different TE types involved in these insertional mutations and elaborate on particularly interesting cases. We also discuss differences and similarities between the mutational role of TEs in mice and humans. Keywords: Endogenous retroviruses, Long terminal repeats, Long interspersed elements, Short interspersed elements, Germ line mutation, Inbred mice, Insertional mutagenesis, Transcriptional interference Background promoter and polyadenylation motifs and often a splice The mouse and human genomes harbor similar types of donor site [10, 11]. Sequences of full-length ERVs can TEs that have been discussed in many reviews, to which encode gag, pol and sometimes env, although groups of we refer the reader for more in depth and general infor- LTR retrotransposons with little or no retroviral hom- mation [1–9]. In general, both human and mouse con- ology also exist [6–9]. While not the subject of this re- tain ancient families of DNA transposons, none view, ERV LTRs can often act as cellular enhancers or currently active, which comprise 1–3% of these genomes promoters, creating chimeric transcripts with genes, and as well as many families or groups of retrotransposons, have been implicated in other regulatory functions [11– which have caused all the TE insertional mutations in 13].
[Show full text]
Mapping Our Genes—Genome Projects: How Big? How Fast?
Mapping Our Genes—Genome Projects: How Big? How Fast? April 1988 NTIS order #PB88-212402 Recommended Citation: U.S. Congress, Office of Technology Assessment, Mapping Our Genes-The Genmne Projects.’ How Big, How Fast? OTA-BA-373 (Washington, DC: U.S. Government Printing Office, April 1988). Library of Congress Catalog Card Number 87-619898 For sale by the Superintendent of Documents U.S. Government Printing Office, Washington, DC 20402-9325 (order form can be found in the back of this report) Foreword For the past 2 years, scientific and technical journals in biology and medicine have extensively covered a debate about whether and how to determine the function and order of human genes on human chromosomes and when to determine the sequence of molecular building blocks that comprise DNA in those chromosomes. In 1987, these issues rose to become part of the public agenda. The debate involves science, technol- ogy, and politics. Congress is responsible for ‘(writing the rules” of what various Federal agencies do and for funding their work. This report surveys the points made so far in the debate, focusing on those that most directly influence the policy options facing the U.S. Congress, The House Committee on Energy and Commerce requested that OTA undertake the project. The House Committee on Science, Space, and Technology, the Senate Com- mittee on Labor and Human Resources, and the Senate Committee on Energy and Natu- ral Resources also asked OTA to address specific points of concern to them. Congres- sional interest focused on several issues: ● how to assess the rationales for conducting human genome projects, ● how to fund human genome projects (at what level and through which mech- anisms), ● how to coordinate the scientific and technical programs of the several Federal agencies and private interests already supporting various genome projects, and ● how to strike a balance regarding the impact of genome projects on international scientific cooperation and international economic competition in biotechnology.
[Show full text]
Heřmanský–Pudlák Syndrome: a Case Report
Int J Case Rep Images 2018;9:100886Z01SB2018. Basu et al. 1 www.ijcasereportsandimages.com CASE REPORT PEER REVIEWED | OPEN ACCESS Heřmanský–Pudlák syndrome: A case report Sonali Someek Basu, Pranav Kumar ABSTRACT care, rehabilitation and multidisciplinary team approach. Heřmanský–Pudlák syndrome (HPS) is hereditary multi system, a rare autosomal Keywords: Gene and data base, Heřmanský– recessive disorder with heterogeneous Pudlák syndrome, Multiple skin cancer, Oculocu- locus characterized by tyrosine positive taneous albinism, Pulmonary fibrosis oculocutaneous albinism, congenital nystagmus, platelet storage pool deficiency - How to cite this article hemorrhagic bleeding tendency and systemic manifestations due to lysosomal accumulation Basu SS, Kumar P. Heřmanský–Pudlák of ceroid lipofuscin in different organs includes syndrome: A case report. Int J Case Rep Images pulmonary fibrosis and granulomatous 2018;9:100886Z01SB2018. enteropathy colitis and renal failure. Depending upon the organ system symptoms and signs, the presentation of HPS can be varied and diagnosis Article ID: 100886Z01SB2018 can be challenging. The most frequently used criteria for diagnosis of HPS as per National Organization of Rare Disease (NORD) revised ********* 2015 are albinism and prolong bleeding. doi: 10.5348/100886Z01SB2018CR Symptoms due to ceroid lipofuscin deposition in lungs, colon, heart and kidneys can occur. Differentiating this condition from other diseases that cause oculocutaneous albinism INTRODUCTION such as ocular albinism, Griscelli syndrome and Chédiak–Higashi syndrome by presence of Heřmanský–Pudlák syndrome (HPS), a rare neurological symptoms and frequent bacterial hereditary disease caused by autosomal recessive infections due to immunodeficiency and analysis inheritance, was first described by Hermansky and of peripheral blood smear with prolong bleeding Pudlakin 1959 [1].
[Show full text]
A Gene for Freckles Maps to Chromosome 4Q32–Q34
A Gene for Freckles Maps to Chromosome 4q32–q34 Xue-Jun Zhang,Ãz1 Ping-Ping He,Ãwz Yan-Hua Liang,Ãwz Sen Yang,Ãz Wen-Tao Yuan,w Shi-Jie Xu,w and Wei Huangw1 ÃInstitute of Dermatology & Department of Dermatology at No.1 Hospital, Anhui Medical University, Hefei, China, wChinese National Human Genome Center at Shanghai, Shanghai, China, zKey Laboratory of Genome Research at Anhui, Hefei, China Freckles are numerous pigmented macules on the face commonly occurring in the Caucasian and Chinese population. As freckling is considered as an independent trait, no gene or locus for it has been identified to date. Here we performed genome-wide scan for linkage analysis in a multigeneration Chinese family with freckles. A maximum LOD score of 4.26 at a recombination fraction of 0 has been obtained with marker D4S1566. Haplotype analysis localized the freckles locus to a 16 Mbp region flanked by D4S2952 and D4S1607. We have thus mapped the gene for freckles to chromosome 4q32–q34. This will aid future identification of the responsible gene, which will be very useful for the understanding of the molecular mechanism of freckles. Key words: freckles/gene mapping/genome-wide scan/linkage analysis. J Invest Dermatol 122:286 –290, 2004 Freckles, or ephelides are numerous pigmented spots of the tion study with the melanocorin-1-receptor (MC1R) gene, skin commonly occurring in the Caucasian population freckles, and solar lentigines, and found that the MC1R (Bastiaens et al, 1999). They are mainly confined to the gene variants could play an important part in the develop- face, even arms and back.
[Show full text]
Supplementary Table 1 Genes Tested in Qrt-PCR in Nfpas
Supplementary Table 1 Genes tested in qRT-PCR in NFPAs Gene Bank accession Gene Description number ABI assay ID a disintegrin-like and metalloprotease with thrombospondin type 1 motif 7 ADAMTS7 NM_014272.3 Hs00276223_m1 Rho guanine nucleotide exchange factor (GEF) 3 ARHGEF3 NM_019555.1 Hs00219609_m1 BCL2-associated X protein BAX NM_004324 House design Bcl-2 binding component 3 BBC3 NM_014417.2 Hs00248075_m1 B-cell CLL/lymphoma 2 BCL2 NM_000633 House design Bone morphogenetic protein 7 BMP7 NM_001719.1 Hs00233476_m1 CCAAT/enhancer binding protein (C/EBP), alpha CEBPA NM_004364.2 Hs00269972_s1 coxsackie virus and adenovirus receptor CXADR NM_001338.3 Hs00154661_m1 Homo sapiens Dicer1, Dcr-1 homolog (Drosophila) (DICER1) DICER1 NM_177438.1 Hs00229023_m1 Homo sapiens dystonin DST NM_015548.2 Hs00156137_m1 fms-related tyrosine kinase 3 FLT3 NM_004119.1 Hs00174690_m1 glutamate receptor, ionotropic, N-methyl D-aspartate 1 GRIN1 NM_000832.4 Hs00609557_m1 high-mobility group box 1 HMGB1 NM_002128.3 Hs01923466_g1 heterogeneous nuclear ribonucleoprotein U HNRPU NM_004501.3 Hs00244919_m1 insulin-like growth factor binding protein 5 IGFBP5 NM_000599.2 Hs00181213_m1 latent transforming growth factor beta binding protein 4 LTBP4 NM_001042544.1 Hs00186025_m1 microtubule-associated protein 1 light chain 3 beta MAP1LC3B NM_022818.3 Hs00797944_s1 matrix metallopeptidase 17 MMP17 NM_016155.4 Hs01108847_m1 myosin VA MYO5A NM_000259.1 Hs00165309_m1 Homo sapiens nuclear factor (erythroid-derived 2)-like 1 NFE2L1 NM_003204.1 Hs00231457_m1 oxoglutarate (alpha-ketoglutarate)
[Show full text]
Supplementary Table 1 Final.Xlsx
Platelet Biology & Its Disorders SUPPLEMENTARY APPENDIX Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects Ben Johnson, 1 Gillian C. Lowe, 1 Jane Futterer, 1 Marie Lordkipanidzé, 1 David MacDonald, 1 Michael A. Simpson, 2 Isabel Sanchez-Guiú, 3 Sian Drake, 1 Danai Bem, 1 Vincenzo Leo, 4 Sarah J. Fletcher, 1 Ban Dawood, 1 José Rivera, 3 David Allsup, 5 Tina Biss, 6 Paula HB Bolton-Maggs, 7 Peter Collins, 8 Nicola Curry, 9 Charlotte Grimley, 10 Beki James, 11 Mike Makris, 4 Jayashree Motwani, 12 Sue Pavord, 13 Katherine Talks, 6 Jecko Thachil, 7 Jonathan Wilde, 14 Mike Williams, 12 Paul Harrison, 15 Paul Gis - sen, 16 Stuart Mundell, 17 Andrew Mumford, 18 Martina E. Daly, 4 Steve P. Watson, 1 and Neil V. Morgan 1 on behalf of the UK GAPP Study Group 1Institute for Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, UK; 2Division of Genetics and Molecular Medicine, King's College, London, UK; 3Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, Mur - cia, Spain; 4Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Medical School, University of Sheffield, UK; 5Hull Haemophilia Treatment Centre, Hull and East Yorkshire Hospitals NHS Trust, Castle Hill Hospital, Hull, UK; 6Depart - ment of Haematology, Royal Victoria Infirmary, Newcastle Upon Tyne, UK; 7Department of Haematology, Manchester Royal Infirmary, Manchester, UK; 8Arthur Bloom Haemophilia Centre, School of Medicine, Cardiff
[Show full text]
Development of the Swimbladder Surfactant System and Biogenesis of Lysosome-Related Organelles Is Regulated by BLOS1 in Zebrafish
| INVESTIGATION Development of the Swimbladder Surfactant System and Biogenesis of Lysosome-Related Organelles Is Regulated by BLOS1 in Zebrafish Tianbing Chen,*,† Guili Song,* Huihui Yang,*,† Lin Mao,*,† Zongbin Cui,*,1 and Kaiyao Huang*,1 *Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan 430072, China and †University of Chinese Academy of Sciences, Beijing 100049, China ABSTRACT Hermansky-Pudlak syndrome (HPS) is a human autosomal recessive disorder that is characterized by oculocutaneous albinism and a deficiency of the platelet storage pool resulting from defective biogenesis of lysosome-related organelles (LROs). To date, 10 HPS genes have been identified, three of which belong to the octamer complex BLOC-1 (biogenesis of lysosome-related organelles complex 1). One subunit of the BLOC-1 complex, BLOS1, also participates in the BLOC-1-related complex (BORC). Due to lethality at the early embryo stage in BLOS1 knockout mice, the function of BLOS1 in the above two complexes and whether it has a novel function are unclear. Here, we generated three zebrafish mutant lines with a BLOC-1 deficiency, in which melanin and silver pigment formation was attenuated as a result of mutation of bloc1s1, bloc1s2, and dtnbp1a, suggesting that they function in the same complex. In addition, mutations of bloc1s1 and bloc1s2 caused an accumulation of clusters of lysosomal vesicles at the posterior part of the tectum, representing a BORC-specific function in zebrafish. Moreover, bloc1s1 is highly expressed in the swimbladder during postembryonic stages and is required for positively regulating the expression of the genes, which is known to govern surfactant production and lung development in mammals.
[Show full text]
MUTED Antibody - C-Terminal Region (ARP63301 P050) Data Sheet
MUTED antibody - C-terminal region (ARP63301_P050) Data Sheet Product Number ARP63301_P050 Product Name MUTED antibody - C-terminal region (ARP63301_P050) Size 50ug Gene Symbol BLOC1S5 Alias Symbols DKFZp686E2287; MU; MUTED Nucleotide Accession# NM_201280 Protein Size (# AA) 187 amino acids Molecular Weight 21kDa Product Format Lyophilized powder NCBI Gene Id 63915 Host Rabbit Clonality Polyclonal Official Gene Full Name Muted homolog (mouse) Gene Family BLOC1S This is a rabbit polyclonal antibody against MUTED. It was validated on Western Blot by Aviva Systems Biology. At Aviva Systems Biology we manufacture rabbit polyclonal antibodies on a large scale (200-1000 Description products/month) of high throughput manner. Our antibodies are peptide based and protein family oriented. We usually provide antibodies covering each member of a whole protein family of your interest. We also use our best efforts to provide you antibodies recognize various epitopes of a target protein. For availability of antibody needed for your experiment, please inquire (). Partner Proteins BLOC1S2,DTNBP1,BLOC1S1,BLOC1S2,CNO,DTNBP1,SNAPIN,BLOC1S2,BLOC1S3,DTNBP1,PLDN,SQS TM1,YOD1 This gene encodes a component of BLOC-1 (biogenesis of lysosome-related organelles complex 1). Components of this complex are involved in the biogenesis of organelles such as melanosomes and platelet- Description of Target dense granules. A mouse model for Hermansky-Pudlak Syndrome is mutated in the murine version of this gene. Alternative splicing results in multiple transcript variants. Read-through transcription exists between this gene and the upstream EEF1E1 (eukaryotic translation elongation factor 1 epsilon 1) gene, as well as with the downstream TXNDC5 (thioredoxin domain containing 5) gene.
[Show full text]
Supplementary Table 2
Supplementary Table 2. Differentially Expressed Genes following Sham treatment relative to Untreated Controls Fold Change Accession Name Symbol 3 h 12 h NM_013121 CD28 antigen Cd28 12.82 BG665360 FMS-like tyrosine kinase 1 Flt1 9.63 NM_012701 Adrenergic receptor, beta 1 Adrb1 8.24 0.46 U20796 Nuclear receptor subfamily 1, group D, member 2 Nr1d2 7.22 NM_017116 Calpain 2 Capn2 6.41 BE097282 Guanine nucleotide binding protein, alpha 12 Gna12 6.21 NM_053328 Basic helix-loop-helix domain containing, class B2 Bhlhb2 5.79 NM_053831 Guanylate cyclase 2f Gucy2f 5.71 AW251703 Tumor necrosis factor receptor superfamily, member 12a Tnfrsf12a 5.57 NM_021691 Twist homolog 2 (Drosophila) Twist2 5.42 NM_133550 Fc receptor, IgE, low affinity II, alpha polypeptide Fcer2a 4.93 NM_031120 Signal sequence receptor, gamma Ssr3 4.84 NM_053544 Secreted frizzled-related protein 4 Sfrp4 4.73 NM_053910 Pleckstrin homology, Sec7 and coiled/coil domains 1 Pscd1 4.69 BE113233 Suppressor of cytokine signaling 2 Socs2 4.68 NM_053949 Potassium voltage-gated channel, subfamily H (eag- Kcnh2 4.60 related), member 2 NM_017305 Glutamate cysteine ligase, modifier subunit Gclm 4.59 NM_017309 Protein phospatase 3, regulatory subunit B, alpha Ppp3r1 4.54 isoform,type 1 NM_012765 5-hydroxytryptamine (serotonin) receptor 2C Htr2c 4.46 NM_017218 V-erb-b2 erythroblastic leukemia viral oncogene homolog Erbb3 4.42 3 (avian) AW918369 Zinc finger protein 191 Zfp191 4.38 NM_031034 Guanine nucleotide binding protein, alpha 12 Gna12 4.38 NM_017020 Interleukin 6 receptor Il6r 4.37 AJ002942
[Show full text]
E-Mutpath: Computational Modelling Reveals the Functional Landscape of Genetic Mutations Rewiring Interactome Networks
bioRxiv preprint doi: https://doi.org/10.1101/2020.08.22.262386; this version posted August 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. e-MutPath: Computational modelling reveals the functional landscape of genetic mutations rewiring interactome networks Yongsheng Li1, Daniel J. McGrail1, Brandon Burgman2,3, S. Stephen Yi2,3,4,5 and Nidhi Sahni1,6,7,8,* 1Department oF Systems Biology, The University oF Texas MD Anderson Cancer Center, Houston, TX 77030, USA 2Department oF Oncology, Livestrong Cancer Institutes, Dell Medical School, The University oF Texas at Austin, Austin, TX 78712, USA 3Institute For Cellular and Molecular Biology (ICMB), The University oF Texas at Austin, Austin, TX 78712, USA 4Institute For Computational Engineering and Sciences (ICES), The University oF Texas at Austin, Austin, TX 78712, USA 5Department oF Biomedical Engineering, Cockrell School of Engineering, The University oF Texas at Austin, Austin, TX 78712, USA 6Department oF Epigenetics and Molecular Carcinogenesis, The University oF Texas MD Anderson Science Park, Smithville, TX 78957, USA 7Department oF BioinFormatics and Computational Biology, The University oF Texas MD Anderson Cancer Center, Houston, TX 77030, USA 8Program in Quantitative and Computational Biosciences (QCB), Baylor College oF Medicine, Houston, TX 77030, USA *To whom correspondence should be addressed. Nidhi Sahni. Tel: +1 512 2379506; Email: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.22.262386; this version posted August 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder.
[Show full text]
SNAPAP Antibody Cat
SNAPAP Antibody Cat. No.: XW-8015 SNAPAP Antibody Specifications HOST SPECIES: Chicken SPECIES REACTIVITY: Human, Mouse, Rat IMMUNOGEN: 31-136 TESTED APPLICATIONS: WB SNARE-associated protein Snapin antibody can be used for the detection of SNARE- APPLICATIONS: associated protein Snapin by Western Blot. PREDICTED MOLECULAR 14.9 kDa (calculated) WEIGHT: Properties PURIFICATION: Immunoaffinity Purified CLONALITY: Polyclonal CONJUGATE: Unconjugated PHYSICAL STATE: Liquid BUFFER: Phosphate-Buffered Saline. No preservatives added. CONCENTRATION: 1 mg/mL October 1, 2021 1 https://www.prosci-inc.com/snapap-antibody-8015.html SNAPAP antibody can be stored at 4˚C for short term (weeks). Long term storage should STORAGE CONDITIONS: be at -20˚C. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures. Additional Info OFFICIAL SYMBOL: SNAPIN BLOC1S7, SNAP25BP, SNAPAP, SNARE-associated protein Snapin, Biogenesis of lysosome- related organelles complex 1 subunit 7, BLOC-1 subunit 7, BLOS7, BLOC1S7, ALTERNATE NAMES: SNAREassociated protein Snapin, Synaptosomal-associated protein 25 binding protein, SNAP-associated protein ACCESSION NO.: NP_036569.1 PROTEIN GI NO.: 6912674 GENE ID: 23557 USER NOTE: Optimal dilutions for each application to be determined by the researcher. Background and References FUNCTION: May modulate a step between vesicle priming, fusion and calcium-dependent neurotransmitter release by potentiating the interaction of synaptotagmins with the SNAREs and the plasma-membrane-associated protein SNAP25. Its phosphorylation state BACKGROUND: influences exocytotic protein interactions and may regulate synaptic vesicle exocytosis. May also have a role in the mechanisms of SNARE-mediated membrane fusion in non- neuronal cells (By similarity).
[Show full text]
Impaired Maturation of Large Dense-Core Vesicles in Muted
ß 2015. Published by The Company of Biologists Ltd | Journal of Cell Science (2015) 128, 1365–1374 doi:10.1242/jcs.161414 RESEARCH ARTICLE Impaired maturation of large dense-core vesicles in muted-deficient adrenal chromaffin cells Zhenhua Hao1,2, Lisi Wei3, Yaqin Feng1,4, Xiaowei Chen3, Wen Du5, Jing Ma1, Zhuan Zhou3, Liangyi Chen3 and Wei Li1,6,* ABSTRACT Previous studies have suggested that the granin family plays an important role in LDCV biogenesis (Kim et al., 2001), but the The large dense-core vesicle (LDCV), a type of lysosome-related machinery for granin sorting into LDCVs is largely unknown. organelle, is involved in the secretion of hormones and The adaptor protein-3 (AP-3) complex is likely involved in granin neuropeptides in specialized secretory cells. The granin family is a sorting into immature LDCVs. In AP-3-deficient chromaffin driving force in LDCV biogenesis, but the machinery for granin sorting cells, LDCVs contain less granins, chromogranin A (CgA, also to this biogenesis pathway is largely unknown. The mu mutant known as CHGA) and secretogranin II (SgII, also known as mouse, which carries a spontaneous null mutation on the Muted gene SCG2), and exhibit enlarged size, decreased number and an (also known as Bloc1s5), which encodes a subunit of the biogenesis increase in releasing quantal size (i.e. the amount of transmitter of lysosome-related organelles complex-1 (BLOC-1), is a mouse released per vesicle) (Asensio et al., 2010; Grabner et al., 2006). model of Hermansky–Pudlak syndrome. Here, we found that LDCVs AP-3 and the HOPS complex interact physically and might act in were enlarged in mu adrenal chromaffin cells.
[Show full text]